Home | About IPJ | Editorial board | Ahead of print | Current Issue | Archives | Instructions | Contact us |   Login 
Industrial Psychiatry Journal
Search Articles   
    
Advanced search   
 
This article has been cited by
1
Alessandro Cuomo,Simone Bolognesi,Arianna Goracci,Despoina Koukouna,Pier Francesco Laurenzi,Andrea Fagiolini
.2020;()109
[DOI]
2Role of Hippocampal Neurogenesis in Alcohol Withdrawal Seizures
Sreetama Basu,Hoonkyo Suh,Kimberly Nixon
Brain Plasticity.2020;6(1)27
[DOI]
3Role of Hippocampal Neurogenesis in Alcohol Withdrawal Seizures
Karl-Heinz Schulz,Sandra van Eckert,Jens Reimer
Brain Plasticity.2015;6(1)65
[DOI]
4Recidivism in Liver Transplant Recipients for Alcohol-related Liver Disease
Narendra S. Choudhary,Neeraj Saraf,Saurabh Mehrotra,Sanjiv Saigal,Arvinder S. Soin
Journal of Clinical and Experimental Hepatology.2021;11(3)387
[DOI]
5Characterization of the GHB Withdrawal Syndrome
Casper J. H. Wolf,Harmen Beurmanjer,Boukje A. G. Dijkstra,Alexander C. Geerlings,Marcia Spoelder,Judith R. Homberg,Arnt F. A. Schellekens
Journal of Clinical Medicine.2021;10(11)2333
[DOI]
6Characterization of the GHB Withdrawal Syndrome
Thomas W. Meeks,Nicole M. Bekman,Nicole M. Lanouette,Kathryn A. Yung,Ryan P. Vienna
Journal of Clinical Medicine.2019;10(11)135
[DOI]
7Adaptation and Validation of a scale to Assess Knowledge, Attitudes, and Perceptions of Healthcare Workers Towards Alcohol Withdrawal and Its Detection
Padma Rani Kumar,Anne Yee,Benedict Francis,Mahmoud Danaee
International Journal of Mental Health and Addiction.2021;10(11)135
[DOI]
8Haloperidol in palliative care: Indications and risks
Iwona Zaporowska-Stachowiak,Katarzyna Stachowiak-Szymczak,Mary-Tiffany Oduah,Maciej Sopata
Biomedicine & Pharmacotherapy.2020;132(11)110772
[DOI]
9Investigating the management of alcohol-related presentations in an Australian teaching hospital
Siyu Qian,Mudar Irani,Renee Brighton,Wilfred Yeo,David Reid,Barbara Sinclair,Susan Bresnahan,Peter Lynch,Xiaoqi Feng,Ping Yu
Drug and Alcohol Review.2019;132(11)110772
[DOI]
10Barbiturates for the treatment of alcohol withdrawal syndrome: A systematic review of clinical trials
Yoonsun Mo,Michael C. Thomas,George E. Karras
Journal of Critical Care.2016;32(11)101
[DOI]
11A multidisciplinary approach to the management of liver disease and alcohol disorders in psychiatric settings (Review)
Simona Trifu,Andrian ?îbîrna,Radu-Virgil Costea,Alexandra Popescu
Experimental and Therapeutic Medicine.2021;21(3)101
[DOI]
12Treatment of alcohol withdrawal syndrome
Y.P. Sivolap
Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova.2021;121(6)139
[DOI]
13Comparison of propofol with midazolam in endoscopic submucosal dissection for esophageal squamous cell carcinoma: a randomized controlled trial
Masaki Ominami,Yasuaki Nagami,Masatsugu Shiba,Kazunari Tominaga,Taishi Sakai,Hirotsugu Maruyama,Kunihiro Kato,Hiroaki Minamino,Shusei Fukunaga,Fumio Tanaka,Satoshi Sugimori,Noriko Kamata,Hirohisa Machida,Hirokazu Yamagami,Tetsuya Tanigawa,Toshio Watanabe,Yasuhiro Fujiwara,Tetsuo Arakawa
Journal of Gastroenterology.2018;53(3)397
[DOI]
14Alcohol withdrawal syndrome management: Is there anything new?
G. Airagnes,G. Ducoutumany,B. Laffy-Beaufils,A.-L. Le Faou,F. Limosin
La Revue de Médecine Interne.2019;40(6)373
[DOI]
15Perioperative administration of patients with alcoholic dependence clinical recommendations
I. B. Zabolotskikh,A. V. Butrov,E. S. Gorobets,E. V. Grigor'ev,K. M. Lebedinsky,A. Yu. Lubnin,A. E. Muronov,A. M. Ovezov,A. M. Ovechkin,A. V. Shegolev
Anesteziologiya i Reanimatologiya.2018;40(1-2)91
[DOI]
16Management of alcohol withdrawal syndrome
Alina Rosca,Ana Giurgiuca
Psihiatru.ro.2018;4(55)12
[DOI]
17Management of alcohol withdrawal syndrome
Maike Eppens
Psihiatru.ro.2016;4(55)46
[DOI]
18Encephalopathic Presentation of West Nile Virus Neuroinvasive Disease Confounded by Concomitant History of Acute Alcohol Withdrawal
Alyssa Profita,Kristin Haglund
Advanced Emergency Nursing Journal.2019;41(4)316
[DOI]
19Closed-Eye Visual Hallucinations Preceding Severe Alcohol Withdrawal
Saral Desai,Anca E Toma,Artem Sunik
Cureus.2021;41(4)316
[DOI]
20Can the alcohol withdrawal scale be applied to post-operative patients?
Kirk Underwood,Douglas Stupart,Frederick Hamish Morgan,Benjamin Scott,Ryan Moxham-Smith,Eileen Mary Moore,Deborah Friedman
ANZ Journal of Surgery.2022;92(6)1377
[DOI]
21Delirium tremens : quoi de neuf pour une vieille maladie ?
N. Thiercelin,A. Plat,A. Garin,J. Azuar
La Revue de Médecine Interne.2021;42(5)330
[DOI]
22Antipsychotic Drugs in Prevention of Postoperative Delirium—What Is Known in 2020?
Michal P. Pluta,Magdalena Dziech,Piotr F. Czempik,Anna J. Szczepanska,Lukasz J. Krzych
International Journal of Environmental Research and Public Health.2020;17(17)6069
[DOI]
23Alcohol consumption during adolescence: A link between mitochondrial damage and ethanol brain intoxication
Cheril Tapia-Rojas,Rodrigo G. Mira,Angie K. Torres,Claudia Jara,María José Pérez,Erick H. Vergara,Waldo Cerpa,Rodrigo A. Quintanilla
Birth Defects Research.2017;109(20)1623
[DOI]
24Expirience of implementation of personalized clinical decision support system for dosing of bromdihydrochlorphenylbenzodiazepine in patients with alcohol withdraw syndrome based on the pharmacogenomic markers
?.?. ?????????,?.?. ???????,?.?. ?????????,?.?. ??????,?.?. ???????,?.?. ?????????,?.?. ????????,?.?. ????????????,?.?. ?????,?.?. ???????,?.?. ??????,?.?. ????????,?.?. ????????,?.?. ????,?.?. ?????
Nauchno-prakticheskii zhurnal «Medicinskaia genetika».2020;109(1())13
[DOI]
25Expirience of implementation of personalized clinical decision support system for dosing of bromdihydrochlorphenylbenzodiazepine in patients with alcohol withdraw syndrome based on the pharmacogenomic markers
?.?. ?????????,?.?. ???????,?.?. ?????????,?.?. ??????,?.?. ???????,?.?. ?????????,?.?. ????????,?.?. ????????????,?.?. ?????,?.?. ???????,?.?. ??????,?.?. ????????,?.?. ????????,?.?. ????,?.?. ?????
Nauchno-prakticheskii zhurnal «Medicinskaia genetika».2017;109(1())199
[DOI]
26Expirience of implementation of personalized clinical decision support system for dosing of bromdihydrochlorphenylbenzodiazepine in patients with alcohol withdraw syndrome based on the pharmacogenomic markers
Sarah Jesse,Albert Ludolph
Nauchno-prakticheskii zhurnal «Medicinskaia genetika».2019;109(1())671
[DOI]
27Delirium tremens: early diagnosis and intensive care guidelines. Review
A.Ye. Muronov
Annals of critical care.2020;109(1)53
[DOI]
28Management of Alcohol Withdrawal Syndrome and Alcohol Withdrawal Seizure
Kyoung Heo,Yang-Je Cho,So-Hee Eun,Sung Chul Lim,Jeehun Lee,Pamela Song
Journal of the Korean Neurological Association.2017;35(3)121
[DOI]
29Alcohol and the Hospitalized Patient
Svetlana Chernyavsky,Patricia Dharapak,Jennifer Hui,Violetta Laskova,Eve Merrill,Kamana Pillay,Evan Siau,Dahlia Rizk
Medical Clinics of North America.2020;104(4)681
[DOI]
30Alcohol and the Hospitalized Patient
Sheeba Khan,Owen Cain,Neil Rajoriya
Medical Clinics of North America.2022;104(4)163
[DOI]
31Entrenamiento en habilidades sociales en cuidadores informales de pacientes con dependencia alcohólica: Una revisión sistemática
Karina Monserrath Pérez Cárdenas,Geovanny Genaro Reivan Ortiz
Pro Sciences: Revista de Producción, Ciencias e Investigación.2022;6(42)184
[DOI]
32Entrenamiento en habilidades sociales en cuidadores informales de pacientes con dependencia alcohólica: Una revisión sistemática
Evangelia Giourou,Alkistis Stavropoulou-Deli,Aspasia Giannakopoulou,George K. Kostopoulos,Michalis Koutroumanidis
Pro Sciences: Revista de Producción, Ciencias e Investigación.2015;6(42)11
[DOI]
33Adjunctive Phenobarbital for Alcohol Withdrawal Syndrome: A Focused Literature Review
Julie A. Murphy,Brittany M. Curran,William A. Gibbons,Holly M. Harnica
Annals of Pharmacotherapy.2021;55(12)1515
[DOI]
34Propofol for Treatment of Refractory Alcohol Withdrawal Syndrome: A Review of the Literature
Amy L. Brotherton,Eric P. Hamilton,H. Grace Kloss,Drayton A. Hammond
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy.2016;36(4)433
[DOI]
35Management of Alcohol Withdrawal Syndrome in Patients with Alcoholic Liver Disease
Prabhat Kumar Chand,Udit Panda,Jayant Mahadevan,Pratima Murthy
Journal of Clinical and Experimental Hepatology.2022;36(4)433
[DOI]
36Comparative efficacy and safety of pharmacotherapies for alcohol withdrawal: a systematic review and network meta-analysis
Anees Bahji,Paxton Bach,Marlon Danilewitz,David Crockford,Nady el-Guebaly,Daniel J. Devoe,Richard Saitz
Addiction.2022;36(4)433
[DOI]
37Alcohol Withdrawal Assessment Tool
Carmen R. Davis,Alyson Keen,Vince Holly,Jean Balaguras,Wendy R. Miller
Clinical Nurse Specialist.2018;32(6)307
[DOI]
38Alcohol withdrawal syndrome: mechanisms, manifestations, and management
S. Jesse,G. Bråthen,M. Ferrara,M. Keindl,E. Ben-Menachem,R. Tanasescu,E. Brodtkorb,M. Hillbom,M.A. Leone,A.C. Ludolph
Acta Neurologica Scandinavica.2017;135(1)4
[DOI]
39Patient Outcomes Associated With Phenobarbital Use With or Without Benzodiazepines for Alcohol Withdrawal Syndrome: A Systematic Review
Drayton A. Hammond,Jordan M. Rowe,Adrian Wong,Tessa L. Wiley,Kristen C. Lee,Sandra L. Kane-Gill
Hospital Pharmacy.2017;52(9)607
[DOI]
40Alcohol use disorder and alcohol withdrawal syndrome in Vietnamese hospitalized patients
Nguyen Thi Mai Loan,Joseph S. Bertino,Tanattha Kittisopee
Alcohol.2019;78(9)51
[DOI]
41Pharmacotherapies for the Treatment of Alcohol Use Disorders During Pregnancy: Time to Reconsider?
Erin Kelty,Mishka Terplan,Melanie Greenland,David Preen
Drugs.2021;81(7)739
[DOI]
42Therapeutic interventions for alcohol dependence in non-inpatient settings: a systematic review and network meta-analysis (protocol)
Hung-Yuan Cheng,Roy G. Elbers,Julian P. T. Higgins,Abigail Taylor,Georgina J. MacArthur,Luke McGuinness,Sarah Dawson,José A. López-López,Sean Cowlishaw,Matthew Hickman,David Kessler
Systematic Reviews.2017;6(1)739
[DOI]
43Lipid profile dysregulation predicts alcohol withdrawal symptom severity in individuals with alcohol use disorder
Daniel B. Rosoff,Katrin Charlet,Jeesun Jung,Jisoo Lee,Christine Muench,Audrey Luo,Martha Longley,Falk W. Lohoff
Alcohol.2020;86(1)93
[DOI]
44Using a personalized clinical decision support system for bromdihydrochlorphenylbenzodiazepine dosing in patients with anxiety disorders based on the pharmacogenomic markers
Michael S. Zastrozhin,Aleksandr S. Sorokin,Tatyana V. Agibalova,Elena A. Grishina,Anastasiya ?. Antonenko,Ilya N. Rozochkin,Denis V. Duzhev,Valentine Y. Skryabin,Tatyana E. Galaktionova,Ilya V. Barna,Anna V. Orlova,Albert D. Aguzarov,Ludmila M. Savchenko,Evgeny A. Bryun,Dmitry A. Sychev
Human Psychopharmacology: Clinical and Experimental.2018;33(6)e2677
[DOI]
45Using a personalized clinical decision support system for bromdihydrochlorphenylbenzodiazepine dosing in patients with anxiety disorders based on the pharmacogenomic markers
E.B. Holmgren,T.A. Wills
Human Psychopharmacology: Clinical and Experimental.2021;160(6)223
[DOI]
46Using a personalized clinical decision support system for bromdihydrochlorphenylbenzodiazepine dosing in patients with anxiety disorders based on the pharmacogenomic markers
Luis Pereira Justo
Human Psychopharmacology: Clinical and Experimental.2016;160(6)37
[DOI]
47Review of thiamine deficiency disorders: Wernicke encephalopathy and Korsakoff psychosis
Abin Chandrakumar,Aseem Bhardwaj,Geert W. ‘t Jong
Journal of Basic and Clinical Physiology and Pharmacology.2019;30(2)153
[DOI]
48Pharmacotherapeutic management of acute alcohol withdrawal syndrome in critically Ill patients
A. Glahn,P. J. Proskynitopoulos,S. Bleich,T. Hillemacher
Expert Opinion on Pharmacotherapy.2020;21(9)1083
[DOI]
  Feedback 
  Subscribe